Global Dyslexia Market 2022
- Ulat sa Market
- ID: HH24527G
- Oras ng Paghahatid: 1 Araw ng Negosyo
- Tag: Dyslexia
Paglalarawan
Dyslexia is a learning disability in reading. People with dyslexia have trouble reading at a good pace and without mistakes. They may also have a hard time with reading comprehension, spelling, and writing. The global dyslexia market is poised to grow by US$ 10.8 bilyon mula sa 2022 sa 2028, pagrehistro ng isang CAGR ng 6.7% sa panahon ng pagtataya, ayon sa StrategyHelix.
Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2018-2021 at forecast na 2028 covering key market aspects like sales value for dyslexia. The global dyslexia market is segmented on the basis of category, type of dyslexia, end user, at rehiyon. Ayon sa kategorya, the global dyslexia market has been segmented into treatment, diagnosis. The treatment segment was the largest contributor to the global dyslexia market in 2021. Based upon type of dyslexia, the global dyslexia market is categorized into phonological dyslexia, surface dyslexia, iba pa ang iba. Ayon sa pananaliksik, the phonological dyslexia segment had the largest share in the global dyslexia market. Sa batayan ng end user, the global dyslexia market has been segmented into specialty centers, home care, mga ospital & clinics, iba pa ang iba. Sa mga tuntunin ng heograpiya, the global dyslexia market has been segmented into Asia Pacific, Europa, Hilagang Amerika, Pahinga ng Mundo (RoW).
The global dyslexia market is highly competitive. The key players in the dyslexia market include Eli Lilly and Company, GSK plc, Lingit AS, Lyfta Oy, Novartis AG, Pfizer Inc., Soli, Speechify Inc., Teva Pharmaceutical Industries Ltd.
Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the dyslexia market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.
Saklaw ng Ulat
Kategorya: treatment, diagnosis
Type of dyslexia: phonological dyslexia, surface dyslexia, iba pa ang iba
End user: specialty centers, home care, mga ospital & clinics, iba pa ang iba
Rehiyon: Asya Pasipiko, Europa, Hilagang Amerika, Pahinga ng Mundo (RoW)
Taon na itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2018 sa 2028
Mga Pangunahing Benepisyo para sa mga Stakeholder
– Get a comprehensive picture of the global dyslexia market
– Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan
Talaan ng mga Nilalaman
Bahagi 1. Panimula
– Saklaw ng pag aaral
– Panahon ng pag aaral
– Saklaw ng heograpiya
– Paraan ng pananaliksik
Bahagi 2. Dyslexia market overview
Bahagi 3. Market breakdown by category
– Treatment
– Diagnosis
Bahagi 4. Market breakdown by type of dyslexia
– Phonological dyslexia
– Surface dyslexia
– Ang iba naman
Bahagi 5. Pagkasira ng merkado sa pamamagitan ng end user
– Specialty centers
– Home care
– Hospitals & clinics
– Ang iba naman
Bahagi 6. Market breakdown by region
– Asya Pasipiko
– Europa
– Hilagang Amerika
– Pahinga ng Mundo (RoW)
Bahagi 7. Mga pangunahing kumpanya
– Eli Lilly and Company
– GSK plc
– Lingit AS
– Lyfta Oy
– Novartis AG
– Pfizer Inc.
– Soli
– Speechify Inc.
– Teva Pharmaceutical Industries Ltd.
Tungkol sa StrategyHelix
Pagtanggi
USD 650